Lineage Cell Therapeutics Provides Update on Renevia® Commercialization Plans

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. FDX
2. CBRS
3. USO
4. KBH
5. HON
6. HTZ
7. MRK
8. SPCX
9. TTWO
10. SPY

Go back to Lineage Cell Therapeutics Provides Update on Renevia® Commercialization Plans
(NYSE: LCTX) Delayed: 1.28 +0.03 (2.40%)
Previous Close $1.25    52 Week High $ 
Open $1.25    52 Week Low $ 
Day High $1.28    P/E N/A 
Day Low $1.25    EPS $ 
Volume 415,706       

(NYSE: LCTX) Delayed: 1.28 +0.03 (2.40%)
Previous Close $1.25    52 Week High $ 
Open $1.25    52 Week Low $ 
Day High $1.28    P/E N/A 
Day Low $1.25    EPS $ 
Volume 415,706